Bolt Biotherapeutics, Inc.
NASDAQ:BOLT
0.6087 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Omzet
| 7.876 | 5.729 | 1.26 | 0.231 | 0.215 | 0 |
| Kosten van de omzet
| 1.884 | 4.891 | 3.672 | 40.357 | 26.002 | 0.302 |
| Brutowinst
| 5.992 | 0.838 | -2.412 | -40.126 | -25.787 | -0.302 |
| Brutowinstmarge
| 0.761 | 0.146 | -1.914 | -173.706 | -119.94 | 0 |
| Onderzoek- en ontwikkelingskosten
| 59.658 | 73.123 | 75.655 | 40.357 | 26.002 | 9.42 |
| Algemene en administratieve kosten
| 22.53 | 22.927 | 18.393 | 9.056 | 5.182 | 2.209 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 22.53 | 22.927 | 18.393 | 9.056 | 5.182 | 2.209 |
| Overige kosten
| 0 | 0 | -6.084 | -11.745 | -0.042 | -0.153 |
| Bedrijfskosten
| 82.188 | 96.05 | 94.048 | 49.413 | 31.184 | 11.629 |
| Bedrijfsresultaat
| -76.196 | -90.321 | -92.788 | -49.182 | -30.969 | -11.629 |
| Bedrijfsresultaat ratio
| -9.674 | -15.766 | -73.641 | -212.909 | -144.042 | 0 |
| Totaal overige inkomsten en kosten netto
| 6.999 | 2.223 | -5.803 | -11.546 | 0.482 | -0.153 |
| Inkomen voor belasting
| -69.197 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
| Inkomen voor belasting ratio
| -8.786 | -15.378 | -78.247 | -262.892 | -141.8 | 0 |
| Belastingkosten
| 1.716 | -2.223 | 5.803 | 11.546 | -0.482 | 0.04 |
| Nettowinst
| -69.197 | -85.875 | -104.394 | -72.274 | -30.005 | -11.589 |
| Nettowinstmarge
| -8.786 | -14.99 | -82.852 | -312.874 | -139.558 | 0 |
| WPA (Winst Per Aandeel)
| -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
| Verwaterde WPA
| -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
| EBITDA
| -74.312 | -88.655 | -85.511 | -36.826 | -30.592 | -11.174 |
| EBITDA ratio
| -9.435 | -15.475 | -67.866 | -159.42 | -142.288 | 0 |